Last edition
News about "Pharmaceutical Manufacturing"
Aptus Pharma plans its next growth phase with a INR 44.88 crore preferential equity issue, focusing on manufacturing, pan-India expansion and global markets.
Pharmaceutical Manufacturing | 24/08/2026 | By News Bureau
Flow Cleanrooms and Supply expands access to DuPont Tyvek IsoClean and Tyvek 400 garments, supporting contamination control in sterile and controlled environments.
Pharmaceutical Manufacturing | 21/08/2026 | By News Bureau
CPHI Milan 2026 Unveils Four Specialist Zones to Accelerate Pharma Manufacturing Innovation
CPHI Milan 2026 will introduce four specialist zones covering AI & technology, cold-chain logistics, labelling and contamination control, creating dedicated platforms for pharma companies to connect with innovators addressing manufacturing, compliance and supply-chain challenges.
Pharmaceutical Manufacturing | 17/08/2026 | By News Bureau
Aurobindo Pharma's Eugia Unit I Receives US FDA Warning Letter
Aurobindo Pharma’s Eugia Pharma Unit I receives a US Food and Drug Administration (FDA) Warning Letter following OAI status, with no impact on existing US supplies.
Pharmaceutical Manufacturing | 14/08/2026 | By News Bureau | 204
Bristol Myers Squibb Invests USD 2.3 Billion in New Houston Manufacturing Campus
Bristol Myers Squibb will invest USD 2.3 billion in a new Houston manufacturing campus, creating nearly 500 skilled jobs and advancing US pharmaceutical innovation.
Pharmaceutical Manufacturing | 12/08/2026 | By News Bureau
Innogen Wins PIC/S GMP Certification for Efsubaglutide Alfa
Innogen Pharmaceuticals has secured PIC/S GMP certification, validating its manufacturing quality and supporting the global expansion of efsubaglutide alfa.
Pharmaceutical Manufacturing | 04/08/2026 | By News Bureau
Cipla's InvaGen Receives US FDA EIR for New York Manufacturing Facility
Cipla's subsidiary InvaGen has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA), marking the successful closure of the inspection at its New York facility.
Pharmaceutical Manufacturing | 04/08/2026 | By News Bureau
RPG Life Sciences Launches Strategic API Growth Initiative
RPG Life Sciences has launched a strategic Active Pharmaceutical Ingredient (API) initiative, with InvAscent investing in RPG Active Pharma and the unit acquiring Actis Generics.
Pharmaceutical Manufacturing | 31/07/2026 | By News Bureau | 626
Trump's Proposed Tariffs on Generic Drug Imports Raise Concerns for India's Pharmaceutical Industry
The US plans to impose a 100 percent tariff on imported generic medicines from August 2028, increasing to 200 percent a year later, prompting Indian drugmakers to reassess export strategies and manufacturing plans.
Pharmaceutical Manufacturing | 23/07/2026 | By News Bureau
Formycon and OneSource Partner to Manufacture Biosimilars
Formycon and OneSource Specialty Pharma have partnered to manufacture biosimilars, with OneSource providing integrated Drug Substance (DS) and Drug Product (DP) manufacturing from its Bengaluru biologics facility.
Pharmaceutical Manufacturing | 15/07/2026 | By News Bureau | 110
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy